Search

Compugen Ltd

Uždarymo kaina

2.28 -4.2

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.24

Max

2.38

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

6.263

68.51

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+110.08% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-45M

225M

Ankstesnė atidarymo kaina

6.48

Ankstesnė uždarymo kaina

2.28

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-05 23:56; UTC

Cooper Companies Inc. shares are roughly flat in after-market trading. Market sentiment reflects concerns from a disappointing ADP employment report showing weak job growth.

2026-08-05 23:56; UTC

News

CACI International reported Q2 sales of $2.71 billion, exceeding expectations. Shares advanced in after-market trading following strong earnings and optimistic full-year guidance.

2026-08-05 23:56; UTC

CEVA Inc shares rose during after-market hours after earlier declines. Broader market sentiment was affected by a disappointing ADP employment report.

2026-08-05 23:56; UTC

Correlated Moves

Shares of KKR & Co Inc are lower in after-market trading, following volatility and a disappointing ADP employment report indicating weak job growth.

2026-08-05 23:56; UTC

L3Harris Technologies shares are higher in after-market hours, despite no specific news. Cautious sentiment follows a disappointing ADP employment report.

2026-08-05 23:56; UTC

Allison Transmission Holdings Inc shares are higher in after-market trading, reaching a high above the 20-day moving average amid a disappointing ADP employment report.

2026-08-05 23:56; UTC

Flex Ltd shares are higher in after-market hours, despite no specific news. Market sentiment reflects concerns from a disappointing ADP employment report.

2026-08-05 23:56; UTC

Correlated Moves

Ennis Inc shares declined in after-market trading, reflecting broader market sentiment following a disappointing ADP employment report indicating weak job growth.

2026-08-05 23:56; UTC

Correlated Moves
News
Social Media

Magnolia Oil & Gas reported net income of $181.8 million and adjusted EPS of $0.99, exceeding estimates, contributing to after-market gains.

2026-08-05 23:56; UTC

Correlated Moves
News

Entergy Corp shares rose in after-market trading, supported by a $35 million contract awarded to ICF for energy efficiency programs.

2026-08-05 23:56; UTC

Tyler Technologies shares advanced in after-hours trading, recovering from an earlier dip. The stock is positioned near the midpoint of its one-month trading range.

2026-08-05 23:56; UTC

Charles River Laboratories is higher in after-market hours, recovering from session lows. Broader market sentiment is affected by a disappointing ADP employment report.

2026-08-05 23:56; UTC

Corsair Gaming Inc shares are higher in after-market trading, reflecting strong performance despite a disappointing ADP employment report affecting market sentiment.

2026-08-05 23:56; UTC

Public Service Enterprise Group shares are higher in after-market trading amid broader market concerns from a disappointing ADP employment report.

2026-08-05 23:56; UTC

Sweetgreen Inc. shares are trading lower in after-market hours, reflecting broader market sentiment following a disappointing ADP employment report.

2026-08-05 23:56; UTC

Correlated Moves

Cheesecake Factory shares decline in after-market trading, retracing earlier gains amid broader market caution following a disappointing ADP employment report.

2026-08-05 23:56; UTC

Biomarin Pharmaceutical Inc shares are higher in after-market hours amid routine trading, with no specific news identified to explain the movement.

2026-08-05 23:56; UTC

Correlated Moves
News

Uranium Energy Corp gains in after-market trading, influenced by Cameco's rise amid cautious market sentiment following a weak ADP employment report.

2026-08-05 23:56; UTC

Correlated Moves

Ultra Clean Holdings shares rose in after-market hours, supported by a significant gain in Veeco Instruments. Broader market sentiment was affected by a weak ADP report.

2026-08-05 23:56; UTC

Snap Inc. shares are lower in after-market trading, with no specific news identified. Broader market sentiment is affected by a disappointing ADP employment report.

2026-08-05 23:56; UTC

NIO Inc shares are higher in after-market trading, despite no specific news. Broader market sentiment is affected by a disappointing ADP employment report.

2026-08-05 23:56; UTC

Aaon Inc. shares are lower in after-market hours, influenced by a disappointing ADP employment report showing only 44,000 private sector jobs added in July.

2026-08-05 23:56; UTC

Correlated Moves
Social Media

Micron Technology Inc shares are lower in after-market hours, following a decline earlier. The stock's movement aligns with Western Digital's significant drop.

2026-08-05 23:56; UTC

Chipotle Mexican Grill shares were roughly flat in after-market trading. Broader market sentiment was influenced by a disappointing ADP employment report.

2026-08-05 23:56; UTC

Ionis Pharmaceuticals shares are lower in after-market hours, influenced by a disappointing ADP employment report revealing only 44,000 private sector jobs added in July.

2026-08-05 23:56; UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

2026-08-05 23:51; UTC

PulteGroup Inc. shares declined in after-market trading, reversing earlier gains amid cautious sentiment following disappointing U.S. employment data from the ADP report.

2026-08-05 23:51; UTC

Travelers Companies Inc. shares are lower in after-market trading, following weak private sector employment growth data from the ADP report.

2026-08-05 23:51; UTC

Correlated Moves

Kimco Realty Corp shares are higher in after-market trading, influenced by the broader real estate sector despite recent economic data indicating slower job growth.

2026-08-05 23:51; UTC

News

Global Net Lease raised its 2026 FFO guidance to $0.82-$0.85, aligning with estimates, contributing to after-market gains following its earnings report.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

110.08% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  110.08%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat